Traders News Source Senior Editor, Mark Roberts Interviews Yftah Ben Yaackov, CEO BYND Cannasoft Enterprises Inc.

Traders News Source Senior Editor, Mark Roberts Interviews Yftah Ben Yaackov, CEO BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN)

Yftah Ben Yaackov
CEO and Director

Professional lawyer since 2004. Specialized in real estate related issues on all aspects of it including real estate corporations, complex sales transactions, real estate unions, real estate taxation. Notary License holder since 2014. Managed large projects of tens of thousands Square meters for a total amount of above 400 million NIS. At the last 5 years yftah has assembled the business activity of 2 of the largest medical cannabis company’s in Israel and has an enormous experience and knowledge in this field.


Full Interview

Thank you giving us your time to answer our questions.

Could you give us a brief overview of your company’s current operations and revenue streams?

The company has 3 main arms: medical cannabis trading, software, and the EZ-G Product

Medical Cannabis Trading:

The company holds an initial permit for trading in medical cannabis without contact with the substance and plans to receive the final license in the coming weeks, this license gives the company the opportunity to contract with existing growing farms for the purchase of medical cannabis, its transfer for processing in the factory and for packaging and for sale in pharmacies

The company has an agreement with Together Pharma, which is one of the largest growing and processing companies in Israel for the purchase of hundreds of kilograms of medical cannabis and its processing in a factory in both Israel and Uganda, and the company will receive Together’s services for the distribution of the Beyond Cannasoft brand in Israel and Germany.

At the same time, the company applied for preliminary approval for the construction of an Indore farm with a size of about 3,000 square meters, as well as an application for the transfer of an existing license owned by one of the company’s partners to the name of the company, and this license grants the possibility of building a greenhouse facility of about 15,000 square meters.

There is currently no revenue from medical cannabis, it is estimated that with the receipt of the license without contact with the substance soon we will begin to see revenues in this area

Regarding the establishment of the farms, the regulation is heavy and long, and the growing field is beginning to become a bit crowded and problematic, and therefore we are acting very carefully in this regard in light of the extensive investments required in it.


Our subsidiary, Bind Beyond Israel, has been providing software services for over 20 years to private and institutional entities in Israel including banks, insurance companies and government and security institutions.

The company’s main area of activity is big data and CRM services.

For over a year and a half, the company has been working on building software dedicated to the field of medical cannabis for assimilation in growing farms and factories in the field.

Our main breakthrough in this matter was about a month ago when one of the leading research institutes in the world – the Weizmann Institute of Science, asked to install the software in the Institute’s habitats and a long-term agreement was signed between the parties on the matter – the agreement has not yet been reported to the public, the implementation of the software will enable rapid and significant development and entry to large customers.

Revenue from the software sector currently stands at several million dollars a year

EZ-G Product

We are in the final stage of acquiring Ziggy Carmel, a company that holds patents in the field of treating vaginal problems using CBD oils in various concentrations such as hemp seeds oil and others.

Upon completion of the transaction in the coming week, we will work to develop and market the product in the US and Europe

Revenues from the product in our assessment will be significant (also according to the opinion of BDO) and will begin in the third quarter of 2023

Could you describe your customer relationship management (CRM) software product, Benefit CRM?

In addition to the above, it can be noted that Benefit software is a user-friendly software, with high interfacing capabilities and managing databases efficiently and wisely

How many clients use Benefit CRM, and can you name some of them?

Today, the company has several dozen customers in Israel, the leaders being the Weizmann Institute of Science, the largest insurance company in Israel – Harel Insurance and dozens of customers from the retail sector.

BCAN has announced its expansion into the Cannabis market on a couple of levels. When will the new Cannabis CRM product be in the market and how does it differ from Benefit CRM?

The new Benefit software for the field of medical cannabis is already ready for work and is installed both at the Weizmann Institute of Science, this is not a difference between the programs but a complementary interface to the main software, database management is conducted using Benefit software while the software is given to the company a special extension to the field of medical cannabis which includes all the elements required for the management and monitoring of crops in this field

Is there a marketing plan in place for Cannabis CRM?

There is a general strategy according to which in the coming year we will continue to develop the software in collaboration with the Weizmann Institute of Science and then turn to marketing the software in Israel and around the world.

The company has also announced an upcoming “Cannabis Farm” operation. When will that farm be operational, and can you describe the operation?

As noted above, in the near future we will focus on trading in medical cannabis through the license for contactless occupation that we plan to receive very soon and in the process we will generate revenues from our private brands that will be produced by Together Pharma, the plan for the establishment of the farms we will implement subject to the appropriate capital raising and with caution and monitoring of the changes that apply in the field of cultivation.

How will BCAN monetize the crop yields from the Cannabis farm?

See the answer above

 What would be your biggest upcoming catalyst for shareholders?

Investment and development in the EZ-G device

Can you describe your future vision for BCAN?

I expect that alongside the company’s development and increased sales from the field of medical cannabis products and sales from medical cannabis software, the company’s significant leap both in terms of its exposure to the public and investors and in terms of significant revenues will come from the development, marketing, and sale of the EZ-G product, which undoubtedly constitutes a unique and interesting and innovative product.

Thank you for your time,

The Traders News Team


Privacy Policy and Disclaimer
Your Consent
By using our site, you consent to our online privacy policy and disclaimer.
Do we disclose any information to outside parties?
We do not sell your information to anyone.
What information do we collect?
We collect information from you when you subscribe to our newsletter or fill out a form on one of our social platforms. This includes your email address and or mobile phone number.
When registering on our site, as appropriate, you may be asked to enter your: e-mail address and or mobile number.
What do we use your information for?
When we collect your email or mobile number it is used for one purpose to send you the information you requested about small cap stocks. Please read our disclaimer carefully before viewing our emails.
Your information, whether public or private, will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever, other than for the express purpose of delivering the information on small cap stocks that you requested.
We send periodic emails.
The email address you provide may be used to send you information, the small cap stock reports you requested, respond to inquiries, and/or other requests or questions.
How do we protect your information?
We implement a variety of security measures to maintain the safety of your personal information when you enter, submit, your email address. We use secure third parties to send email and sms messages to you.
Because we value your privacy we have taken the necessary precautions to be in compliance with the California Online Privacy Protection Act.
Online Privacy Policy Policy
This online privacy policy applies to information collected through our website and social media platforms.
Contacting Us
If there are any questions regarding this privacy policy or disclaimer you may contact us using the information below.
Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
Please Note: TNS LLC and its employees are not a registered investment advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice.
All information on featured companies is provided by the companies profiled, or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.
TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The owners and operators of this website have been compensated twenty five thousand dollars cash via bank wire by triple crown consulting for this weeks coverage of bcan. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement.
TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.
TNS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA. TNS LLC is not a Broker/Dealer and does not engage in high frequency trading.